JK News Today
Jammu , December 27 : Vaccine maker Bharat Biotech’s intranasal vaccine for COVID-19, the first in the world, is scheduled to be introduced in the country as a booster dose shortly.
The vaccine, iNCOVACC (BBV154), is now available on CoWin, and priced at Rs 800 for private markets and Rs 325 for supplies to the Centre and state governments, the Hyderabad-based company said.
Last month, Bharat Biotech received approval from the Central Drugs Standard Control Organization (CDSCO) for the use of heterologous booster doses of iNCOVACC.
We have achieved the goals we set for ourselves during this pandemic. We have developed COVAXIN and iNCOVACC, two COVID-19 vaccines from two different platforms, with two different delivery systems. The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics,” said Bharat Biotech Executive Chairman Dr Krishna Ella.
He thanked the Ministry of Health, CDSCO, Dept of Biotechnology, Government of India, Technology Development Board, and Washington University, St Louis, for their support and guidance.
As a needleless vaccination, Bharat Biotech’s iNCOVACC will be India’s first such booster dose. India will now have more options when it comes to third doses or precautionary doses.
